WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis

Abstract Background Doxorubicin (DOX)-induced cardiotoxicity (DIC) is a major impediment to its clinical application. It is indispensable to explore alternative treatment molecules or drugs for mitigating DIC. WGX50, an organic extract derived from Zanthoxylum bungeanum Maxim, has anti-inflammatory...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Panpan Tai, Xinyu Chen, Guihua Jia, Guanjun Chen, Lian Gong, Yaxin Cheng, Zhuan Li, Heng Wang, Aiyan Chen, Ganghua Zhang, Yuxing Zhu, Mengqing Xiao, Zhanwang Wang, Yunqing Liu, Dongyong Shan, Dong He, Moying Li, Tianzuo Zhan, Abbas Khan, Xiaohui Li, Xiangxiang Zeng, Chaopeng Li, Dongsheng Ouyang, Kelong Ai, Xuan Chen, Dongbo Liu, Zhonghua Liu, Dongqing Wei, Ke Cao
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-11-01
Colecção:	Journal of Translational Medicine
Assuntos:	WGX50 DOX-induced cardiotoxicity Mitochondrial ROS GPX4 Ferroptosis
Acesso em linha:	https://doi.org/10.1186/s12967-023-04715-1
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!